On June 2, 2018, Board of Directors of DelMar Pharmaceuticals, Inc. announced that Dr. Erich Mohr, step down from his role as Chairman of the Board and as a member of the company's Board to pursue other business opportunities, effective immediately. Dr. Mohr's decision to resign from the Board was not the result of any disagreement or dispute with the company relating to its operations, policies or practices. In connection with Dr. Mohr's resignation, Robert E. Hoffman has been appointed to serve as Chairman of the Board.